Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
NITROX, LLC
ClinicalTrials.gov Identifier:
NCT00323024
First received: May 5, 2006
Last updated: August 29, 2007
Last verified: July 2006
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given